Fertility drugs and ovarian cancer

Gynecological Endocrinology

Volumn 11, Issue 1, 1997, Pages 59-68

  Artini, P G ^a   Fasciani, A ^a   Cela, V ^a   Battaglia, C ^b   De Micheroux, A A ^a   D'Ambrogio, G ^a   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Epidemiology; Fertility treatment; Infertility; Ovarian cancer

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; CYCLOFENIL; FERTILITY PROMOTING AGENT; GONADORELIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT;

AUTOSOMAL DOMINANT INHERITANCE; BREAST FEEDING; CLINICAL EXAMINATION; FEMALE; GONADOTROPIN RELEASE; HUMAN; HYSTERECTOMY; INFERTILITY; OVARY CANCER; OVULATION INDUCTION; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UTERINE TUBE LIGATION;

EID: 0031057001     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599709152318     Document Type: Review

References (88)

1. Heintz, A. P., Hacker, N. F. and Lagasse, L. D. (1985). Epidemiology and etiology of ovarian cancer: a review. Obstet. Gynecol., 66, 127-35
2. Di Saia, P. J. (1990). Ovarian disorders. In Scott, J. R., Di Saia, P. J., Hammond, C. B. and Spellacy, W. N. (eds.) Danforth's Obstetrics and Gynecology, 6th edn., pp. 1067-120. (Philadelphia: J.B. Lippincott Co.)
3. Trimble, E. L. (1994). The NIH Consensus Conference on Ovarian Cancer: Screening, Treatment, and Follow-up. Gynecol. Oncol., 55, S1-S3
4. Schenker, J. G. and Ezra, Y. (1994). Complications of assisted reproductive techniques. Fertil. Steril., 61, 411-22
5. Cutler, S. J. and Young, J. L. (eds.) (1975). Third National Cancer Survey: Incidence Data, Natl. Cancer Inst. Monogr., 41, DHEW publication (NIH), pp. 775-87. (Washington: Government Printing Office)
6. Kolstad, P. and Beecham, J. C. (1975). Epidemiology of ovarian neoplasia. In de Watteville et al. (eds.) Diagnosis and Treatment of Ovarian Neoplastic Alterations, pp. 56-62. (Amsterdam: Excerpta Medica)
7. Lingeman, C. M. (1974). Etiology of cancer of the human ovary: a review. J. Natl. Cancer Inst., 53, 1603
8. Parazzini, F., Franceschi, S., La Vecchia, C. and Fasoli, M. (1991). The epidemiology of ovarian cancer. Gynecol. Oncol., 43, 9-23
9. Hartge, P., Schiffman, M. H., Hoover, R., McGowan, L., Lesher, L. and Norris, H. J. (1989). A case-control study of epithelial ovarian cancer. Am. J. Obstet. Gynecol., 161, 10-16
10. Reyes, F. I., Winter, J. S. D. and Failman, C. (1977). Pituitary-ovarian relationships preceding the menopause. I. A cross selectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am. J. Obstet. Gynecol., 129, 557-64
11. Chakravarti, S., Collins, W. P., Forecast, J. D., Newton, J. R., Oram, D. H. and Studd, J. W. W. (1976). Hormonal profiles after the menopause. Br. Med. J., 2, 784-6
12. Stadel, B. V. (1975). The etiology and prevention of ovarian cancer. Am. J. Obstet. Gynecol., 123, 772-3
13. Mohle, J., Whittemore, A. S., Pike, M., Darby, S. and Cramer, D. (1985). Letters to the Editor. J. Natl. Cancer Inst., 75, 178-80
14. Booth, M., Beral, V. and Smith, P. (1989). Risk factors for ovarian cancer: a case control study. Br. J. Cancer, 60, 592-8
15. Pike, M. C. and Chilvers, C. (1985). Oral contraceptive and breast cancer. The current controversy. J. R. Soc. Health, 105, 5-10
16. Franceschi, S. (1989). Reproductive factors and cancers of the breast, ovary and endometrium. Eur. J. Cancer Clin. Oncol., 25, 1933-43
17. Ron, E., Lunenfeld, B., Menczer, J., Blumstein, T., Katz, L., Oelsner, G. and Serr, D. (1987). Cancer incidence in a cohort of infertile women. Am. J. Epidemiol., 125, 780-90
18. Cramer, D. W., Hutchison, G. B., Welch, W. R., Scully, R. E. and Ryan, K. J. (1983). Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J. Natl. Cancer Inst., 71, 711-16
19. Nasca, P. C., Greenwald, P., Chorost, S., Richart, R. and Caputo, T. (1984). An epidemiologic case-control study of ovarian cancer and reproductive factors. Am. J. Epidemiol., 119, 705-13
20. La Vecchia, C., Decarli, A., Franceschi, S., Regallo, M. and Tognoni, G. (1984). Age at first birth and the risk of epithelial ovarian cancer. J. Natl. Cancer Inst., 73, 663-6
21. McGowan, L., Norris, H. J., Hartge, P., Hoover, R. and Lesher, L. (1988). Risk factors in ovarian cancer. Eur. J. Gynaecol. Oncol., 9, 195-9
22. Whittemore, A. S., Harris, R., Itnyre, J., Halpern, J. and the Collaborative Ovarian Cancer Group (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Am. J. Epidemiol., 136, 1175-83
23. Whittemore, A. S., Harris, R., Itnyre, J. and the Collaborative Ovarian Cancer Group (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am. J. Epidemiol., 136, 1184-203
24. Harris, R., Whittemore, A. S., Itnyre, J. and the Collaborative Ovarian Cancer Group (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am. J. Epidemiol., 136, 1204-11
25. Whittemore, A. S., Harris, R., Itnyre, J. and the Collaborative Ovarian Cancer Group (1992). Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am. J. Epidemiol., 136, 1212-20
26. Adami, H. O., Hsieh, C., Lambe, M., Trichopoulos, D., Leon, D., Persson, I., Ekbom, A. and Janson, P. O. (1994). Parity, age at first childbirth, and risk of ovarian cancer. Lancet, 344, 1250-4
27. Taylor, R. S., Carroll, B. E. and Lloyd, J. W. (1959). Mortality among women in three catholic religious orders with special references to cancer. Cancer, 12, 1207-25
28. Fraumeni, J. F., Lloyd, J. W., Smith, E. M. et al. (1969). Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. J. Natl. Cancer Inst., 42, 455-68
29. Lund, E. (1992). Mortality from ovarian cancer among women with many children. Int. J. Epidemiol., 21, 872-6
30. Cramer, D. W., Hutchison, G. B., Welch, W. R., Scully, R. E. and Knapp, R. C. (1982). Factors affecting the association of oral contraceptives and ovarian cancer. N. Engl. J. Med., 307, 1047-51
31. Rasmussen, A. T. (1934). The weight of the principal components of the normal hypophysis cerebri of the adult human female. Am. J. Anal., 55, 253-75
32. Balasch, J. and Barri, P. N. (1993). Follicular stimulation and ovarian cancer? Hum. Reprod., 8, 990-6
33. Joly, D. J., Lilenfield, A. M. and Diamond, E. L. (1974). An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am. J. Epidemiol., 99, 190-209
34. Bengtsson, M., Hamberger, L. and Rydstrom, J. (1988). Metabolism of 7,12-dimethylbenz(a)anthracene by different types of cells in the human ovary. Xenobiotica, 18, 1255-70
35. Cramer, D. W., Welch, W. R., Scully, R. E. and Wojciechowski, C. A. (1982). Ovarian cancer and talc: a case-control study. Cancer, 50, 372-6
36. Nikrui, N. (1985). Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol. Oncol., 12, 107-19
37. Aure, J. C., Hoeg, K. and Kolstad, P. (1971). Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases. Obstet. Gynecol., 37, 1-9
38. Julian, C. G. and Woodruff, J. D. (1972). The biologic behavior of low grade papillary serous carcinoma of the ovary. Obstet. Gynecol., 40, 860-7
39. Harlow, B. L., Weiss, N. S. and Lofton, S. (1987). Epidemiology of borderline ovarian tumors. J. Natl. Cancer Inst., 78, 71-4
40. Scully, R. E. (1982). Common epithelial tumors of borderline malignancy (carcinoma of low malignant potential). Bull. Cancer (Paris), 69, 228-38
41. Colgan, T. J. and Norris, H. J. (1983). Ovarian epithelial tumors of low malignant potential: a review. Int. J. Gynecol. Pathol., 1, 376-82
42. Nicosia, S. and Nicosia, R. (1988). Neoplasm of the ovarian mesothelium. In Azar, H. (ed.) Pathology of Human Neoplasm, pp. 435-86. (New York: Raven Press)
43. Cramer, D. W. and Welch, W. R. (1983). Determinants of ovarian cancer risk. II. Interferences regarding pathogenesis. J. Natl. Cancer Inst., 71, 717-21
44. Gondos, B. (1975). Surface epithelium of the developing ovary. Am. J. Pathol., 81, 303-12
45. Vierikko, P., Kauppilla, A. and Vihko, R. (1983). Cytosol and nuclear estrogen and progesterone receptors and 17β-hydroxysteroid dehydrogenase activity in nondiseased tissue and in benign and malignant tumors of the human ovary. Int. J. Cancer, 32, 413-22
46. Richman, C. M., Holt, J. A., Lorincz, M. A. and Herbst, A. L. (1985). Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet. Gynecol., 65, 257-63
47. Bizzi, A., Codegoni, A. M., Landoni, F., Marelli, G., Marsoni, S., Spina, A. M., Torri, W. and Mangioni, C. (1988). Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival. Cancer Res., 48, 6222-6
48. Nash, J. P., Ozols, R. F., Smyth, J. F. et al. (1989). Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet. Gynecol., 73, 1009-16
49. Friberg, L. G., Kullander, S., Persijn, J. P. and Korsten, C. B. (1978). On receptors for estrogens (E2) and androgens (DHT) in human endometrial and ovarian tumors. Acta Obstet. Gynecol. Scand., 57, 261-4
50. Holt, J. A., Caputo, T. A., Kelly, K. M., Greenwald, P. and Chorost, S. (1979). Estrogen and progestin binding in cytosol of ovarian carcinoma. Obstet. Gynecol., 53, 50-8
51. Galli, M. C., De Giovanni, C., Nicoletti, G., Grilli, S. et al. (1981). The occurrence of multiple steroid hormone receptors in disease-free and neoplastic human ovary. Cancer, 47, 1297-302
52. Nicosia, S. and Saunders, B. (1986). Corpus luteum extract stimulates the growth of ovarian surface epithelial cells. Lab. Invest., 54, 47a
53. Oka, Y. and Ortho, D. (1983). Human plasma epidermal growth factor/β-urogastrone is associated with blood platelets. J. Clin. Invest., 72, 249-59
54. Davy, M., Torjesen, P. A. and Aakvaag, A. (1977). Demonstration of an FSH receptor in a functioning granulosa cell tumour. Acta Endocrinol., 85, 615-23
55. Stouffer, R. L., Grodin, M. S., Davis, J. R. and Surwit, E. A. (1984). Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. J. Clin. Endocrinol. Metab., 59, 441-6
56. Graves, P. E., Surwit, E. A., Davis, J. R. and Stouffer, R. L. (1985). Adenylate cyclase in human ovarian cancer: sensitivity to gonadotropins and non hormonal activators. Am. J. Obstet. Gynecol., 153, 877-82
57. Nakano, R., Kitayama, S., Yamoto, M., Shima, K. and Ooshima, A. (1989). Localization of gonadotropin binding sites in human ovarian neoplasm. Am. J. Obstet. Gynecol., 161, 905-10
58. Schally, A. V. (1989). The use of LH-RH analogs in gynecology and tumor therapy. In Belfort, P., Pinotti, J. A. and Eskes, T. K. A. B. (eds.) Advances in Gynecology and Obstetrics: General Gynecology, Vol. 6, pp. 3-20. (Carnforth, UK: Parthenon Publishing)
59. Schally, A. V. (1993). Luteinizing hormone-releasing hormone analogs in medicine. In Rodriguez-Armas, O. (ed.) Fertility and Sterility: Progress in Research and Practice. The Proceedings of the XIV World Congress on Fertility and Sterility, pp. 233-61, Caracas, Venezuela, 1992. (Carnforth, UK: Parthenon Publishing)
60. Schally, A. V., Bajusz, S., Redding, D. W., Zalatnai, A. and Comaru-Schally, A. M. (1989). Analogs of LH-RH: the present and the future. In Vickery, B. H. and Lunenfeld, B. (eds.) GnRH Analogues in Cancer and Human Reproduction, Vol. 1, pp. 5-31. (Dordrecht: Kluwer)
61. Emons, G. and Schally, A. V. (1994). The use of luteinizing hormone-releasing hormone agonists and antagonists in gynaecological cancers. Hum. Reprod. Update, 9, 1364-79
62. Yano, T., Pinski, J., Radulovic, S. and Schally, A. V. (1994). Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA, 91, 1701-5
63. Emons, G., Ortmann, O., Becker, M., Irmer, G., Springer, B. Laun, R., Hölzel, F., Schulz, K.-D. and Schally, A. V. (1993). High affinity binding and direct antiproliferative effects of LH-RH analogues in human ovarian cancer cell lines. Cancer Res., 54, 5439-46
64. Klingmuller, D., Schepke, M., Enzweiler, C. and Bidlingmaier, F. (1993). Hormonal responses to the new potent GnRH antagonist Cetrorelix. Acta Endocrinol., 128, 15-18
65. Manetta, A., Gamboa-Vujicic, G., Paredes, P., Emma, D., Liao, S., Leong, L., Asch, B. and Schally, A. (1995). Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75). Fertil. Steril., 63, 282-7
66. Fathalla, M. F. (1971). Incessant ovulation - a factor in ovarian neoplasia? Lancet, 2, 163
67. Lowry, S., Russel, H., Hickey, I. and Atkinson, R. (1991). Incessant ovulation and ovarian cancer. Lancet, 337, 1544-5
68. Casagrande, J. T., Pike, M. C., Ross, R. K., Louie, E. W., Roy, S. and Henderson, B. E. (1979). 'Incessant ovulation' and ovarian cancer. Lancet, 2, 170-3
69. Fishel, S. and Jackson, P. (1989). Follicular stimulation for high tech pregnancies: are we playing it safe? Br. Med. J., 299, 309-11
70. Tarlatzis, B. C., Grimbizis, G., Bontis, J. and Mantalenakis, S. (1995). Ovarian stimulation and ovarian tumours: a critical reappraisal. Hum. Reprod. Update, 1, 284-301
71. Goldberg, G. L. and Runowicz, C. D. (1992). Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation - is there a link? Am. J. Obstet. Gynecol., 166, 853-4
72. Burger, C. W., Nijman, H. W., Baak, J. P. A., Schats, R., Vermarken, J. B., Schoemaker, J. and Kenemans, P. (1983). Borderline tumor of the ovary (BTO) and controlled hyperstimulation, a report of two cases. Hum. Reprod., 8 (Suppl. 1), 144
73. Lopes, P. and Mensier, A. (1993). Ovarian cancer and assisted reproductive technology. Eur. J. Obstet. Gynecol. Reprodc. Biol, 51, 171-3
74. Ben-Hur, H., Dgani, R., Lancet, M., Katz, Z., Nissim, F. and Rosenman, D. (1986). Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet. Gynecol. Scand., 65, 813-14
75. Kulkarni, R. and McGarry, J. M. (1989). Follicular stimulation and ovarian cancer. Br. Med. J., 299, 740
76. Johannes, J. B., Caro, J. J., Hartz, S. C. and Marrs, R. (1993). Adverse effects of ovulatory stimulants: a review. Assist. Reprod. Rev., 3, 68-74
77. Bamford, P. N. and Steele, S. J. (1982). Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br. J. Obstet. Gynaecol., 89, 962-4
78. Atlas, M. and Menczer, J. (1982). Massive hyperstimulation and borderline carcinoma of the ovary. Acta Obstet. Gynecol. Scand., 61, 261-3
79. Carter, M. E. and Joyce, D. N. (1987). Ovarian carcinoma in a patient hyperstimulated by gonadotrophin therapy for in vitro fertilization: a case report. J. In Vitro Fertil. Embryo Transfer, 4, 126-8
80. Dietl, J. (1991). Ovulation and ovarian cancer. Lancet, 338, 445
81. Grimbizis, G., Tarlatzis, B. C., Bontis, J., Miliaras, D., Lagos, S., Pournaropoulos, F. and Mantalenakis, S. (1995). Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts. Hum. Reprod., 10, 520-3
82. Lopes, P., Julou, V., Mensier, A., Gamier, J. M., Laborde, O., Sagot, P., L'Hermite, A., Jean, M. and Barriere, P. (1992). Cancer de l'ovaire et procréation médicalement assistée. Contracept. Fertil. Sexual., 20, 797-8
83. Cohen, J., Forman, R., Harlap, S., Johannisson, E., Lunenfeld, B., de Mouzon, J., Pepperell, R., Tarlatzis, B. and Templeton, A. (1993). IFFS Expert Group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum. Reprod., 8, 996-1000
84. International Federation of Fertility Societies (1993). Fertility drugs and ovarian cancer. Fertil. Steril., 60, 406-8
85. Walters, D. E. (1994). Ovarian cancer and pregnancy: comment on a paper by Whittemore et al. Fertil. Steril., 61, 239-42
86. Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E. and Self, S. G. (1994). Ovarian tumors in a cohort of infertile women. N. Engl. J. Med., 331, 771-6
87. Venn, A., Watson, L., Lumley, J., Giles, G., King, C. and Healy, D. (1995). Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet, 346, 995-1000
88. Willemsen, W., Kruitwagen, R., Bastiaans, B., Hanselaar, T. and Rolland, R. (1993). Ovarian stimulation and granulosa cell tumor. Lancet, 341, 986-8